Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery

References

• Akhilesh D, Bini KB, Kamath JV. (2012). Review on span-60 based non-ionic surfactant vesicles (niosomes) as novel drug delivery. Int J Res Pharm Biomed Sci 3:6–12
   Google Scholar
• Bhosale NR, Hardikar SR, Bhosale AV. (2011). Formulation and evaluation of transdermal patches of ropinirole hydrochloride. Res J Pharm Biol Chem Sci 2:138–80
   Google Scholar
• Clissold SP, Lynch S, Sorkin EM. (1987). Buflomedil: a review of its pharmacodynamics and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. Drugs 33:430–60
   PubMed Web of Science ®Google Scholar
• Das MK, Palei NN. (2011). Sorbitan ester niosomes for topical delivery of rofecoxib. Ind J Exp Biol 49:438–45
   PubMed Web of Science ®Google Scholar
• Dharashivkar S, Shasrabuddhe S, Saoji A. (2014). Silver sulfadiazine niosomes: a novel sustained release once a day formulation for burn treatment. Int J Pharm Pharm Sci 6:611–16
   Google Scholar
• Eicher T, Hauptmann S, Specicher A. (2009). The chemistry of heterocycles: structures, reactions, synthesis and application. 3rd ed. Weinheim: Wiley Publishers
   Google Scholar
• El-Desoky HS, Ghoneim MM, Abdel-Galeil MM. (2010). Quantification of the vasoactive agent buflomedil hydrochloride in pharmaceutical formulation and human serum by stripping voltametry and liquid chromatography. Acta Chim Slov 57:332–40
   PubMed Web of Science ®Google Scholar
• Fang J-Y, Hong C-T, Chiu W-T, Wang Y-Y. (2011). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72
   Web of Science ®Google Scholar
• Gaikwad AK. (2013). Transdermal drug delivery system: formulation aspects and evaluation. Comprehensive J Pharm Sci 1:1–10
   Google Scholar
• Israelachvili J. (1994). The science and applications of emulsions: an overview. Colloids Surf A: Physiochem Eng Aspects 91:1–8
   Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala S. (2014). Formulation and characterization of drug loaded non-ionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Sci World J 2014:1–8
   Web of Science ®Google Scholar
• Liu X, Liu H, Liu J, et al. (2011). Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomed 6:241–7
   PubMed Web of Science ®Google Scholar
• Mamatha T, Rao JV, Ramesh G. (2010). Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in vitro characterization. DARU J Faculty Pharm 18:9–16
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces 30:129–38
   Web of Science ®Google Scholar
• Masterjohn C. (2005). Cholesterol and health. Cholesterol Biochem 1:1–3
   Google Scholar
• Maurya SD, Prajapati SK, Gupta AK, et al. (2010). Formulation development and evaluation of ethosomes of stavudine. Ind J Pharm Educ Res 44:102–8
   Web of Science ®Google Scholar
• Muri EMF, Sposito MMM, Metsavaht L. (2010). Pharmacology of vasoactive drugs. Acta Fisiatr 17:22–7
   Google Scholar
• Ohvo-Rekila H, Ramstedt B, Leppimaki P, Slotte JP. (2002). Cholesterol interactions with phospholipids in membranes. Prog Lipid Res 41:66–97
   PubMed Web of Science ®Google Scholar
• Patel RP, Patel G, Baria A. (2009). Formulation and evaluation of transdermal patch of aceclofenac. Int J Drug Deliv 1:41–51
   Google Scholar
• Peltonen L. (2001). The interfacial behaviour of sorbitan surfactant monolayers and the bulk properties of these surfactants as function of temperature [Dissertation]. Biocentri Viikki Universitatis Helsingiensis
   Google Scholar
• Prajapati RK, Mahajan HS, Surana SJ. (2011a). PLGA based mucoadhesive microspheres for nasal delivery: in vitro/ex vivo studies. Ind J Novel Drug Deliv 3:9–16
   Google Scholar
• Prajapati ST, Patel CG, Patel CN. (2011b). Formulation and evaluation of transdermal patch of repaglinide. ISRN Pharm 2011:1–9
   Google Scholar
• Prasanthi D, Lakshmi PK. (2012). Vesicles-mechanism of transdermal permeation: a review. Asian J Pharm Clin Res 5:18–25
   Google Scholar
• Prausnitz MR, Langer R. (2008). Transdermal drug delivery. Nat Biotechnol 26:1261–8
   PubMed Web of Science ®Google Scholar
• Rahimpour Y, Hamishehkar H. (2012). Niosomes as carrier in dermal drug delivery. In: Demir A. ed. Recent advances in novel drug carrier systems. InTech- Open Science Open Minds, 141–64
   Google Scholar
• Rama B, Shantha A. (2012). Optimization of methotrexate transdermal patches: effect of variables on in vitro, ex vivo permeation and flux. Int J Pharm Sci Lett 2:53–9
   Google Scholar
• Roesken F, Uhl E, Curri SB, et al. (2000). Acceleration of wound healing by drug delivery via liposomes. Langenbecks Arch Surg 385:42–9
   PubMed Web of Science ®Google Scholar
• Sakthivel M, Kannan K, Manavalan R, Senthamasai R. (2012). Formulation and in vitro evaluation of niosomes containing oxcarbazepine. Int J Pharmacy Pharm Sci 4:563–7
   Google Scholar
• Verma PRP, Chandak AR. (2009). Development of matrix controlled transdermal delivery system of pentazocine. Acta Pharm 59:171–86
   PubMed Web of Science ®Google Scholar
• Wahid A, Sridhar BK, Shivakumar S. (2008). Preparation and evaluation of transdermal drug delivery system of etoricoxib using modified chitosan. Ind J Pharm Sci 70:455–60
   PubMed Web of Science ®Google Scholar
• Webb SR. (1971). Small incomplete factorial experiment design for two- and three-level factors. Technometric 13:243–6
   Web of Science ®Google Scholar
• Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L. (2009). Preparation of matrine ethosomes, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res 19:155–62
   PubMed Web of Science ®Google Scholar